NCT01787149 - A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2019

Conditions

Combination With DMARDs

Interventions

DRUG

DMARDs

Trial Locations (7)

Cathay General Hospital, Taipei

Cheng Hsin General Hospital, Taipei

Far Eastern Memorial Hospital, Taipei

Mackay Memorial Hospital Institutional, Taipei

National Taiwan University Hospital, Taipei

Taipei City Hospital, Taipei

Taipei Veterans General Hospital, Taipei